Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

Nature Medicine - A major international clinical trial sheds new light on a paediatric brain cancer

back to job offer list
back to clinical trials

Villejuif, 24 April 2026

A novel triple therapy shows promising signs of efficacy in localised lung cancer

back to job offer list
back to clinical trials

Villejuif, 23 April 2026

A novel triple therapy shows promising signs of efficacy in localised lung cancer

The MATISSE study, presented by Professor Fabrice Barlesi, CEO of Gustave Roussy, during a plenary session on clinical trials at the AACR congress, evaluated the addition of a new molecule to the therapeutically validated combination already used for certain patients with non-small cell lung cancer. This novel triple therapy has demonstrated initial promising clinical effects.

Cancer Cell - a French study reveals the mechanism of action of an innovative drug in patients with advanced lung cancer

back to job offer list
back to clinical trials

Villejuif, April 21, 2026

U1355 RAMO-IT - Molecular Radiotherapy and Therapeutic Innovations - Unit members

back to job offer list
back to clinical trials

U1355 RAMO-IT - Molecular Radiotherapy and Therapeutic Innovations
Unit members

Researchers

  • Dr. Lydia MEZIANI (CRCN, INSERM)
  • Dr. Michele MONDINI (CRCN, INSERM)
  • Dr. Charlotte ROBERT (MCU, Paris Saclay, Gustave Roussy, HDR)

Physicians / Pharmacists / Physicists (interfaces)

  • Dr. Frédéric DHERMAIN (PH, Gustave Roussy)
  • Dr. Sébastien GOUY (PU-PH, Gustave Roussy)
  • Dr. Antonin LEVY (PH, MCU, Gustave Roussy)
  • Dr Elaine LIMKIN (PH, Gustave Roussy)

U1355 RAMO-IT - Molecular Radiotherapy and Therapeutic Innovations - publications

back to job offer list
back to clinical trials

U1355 RAMO-IT - Molecular Radiotherapy and Therapeutic Innovations
Major publications

  • Bockel S, El Aichi M, Sun R, Benzazon N, de Kermenguy F, Veres C, Satragno C, Bidault F, Garcia G, Dhermain F, Deutsch E, Robert C. Integration of white matter tracts in stereotactic brain radiotherapy treatment planning with a fully automated atlas-based pipeline. Comput Biol Med. 2026
Image d'illustration
04/15/2026

Latest Advances in Oncology: Gustave Roussy at the AACR Congress

From April 17 to 22, the American Association for Cancer Research (AACR) is holding its annual congress — one of the three leading global scientific conferences dedicated to oncology — in San Diego, United States. More than 20,000 cancer specialists, both clinicians and researchers, from nearly one hundred countries are expected to present and...
Equipe Chirurgie
04/07/2026

Reconstruction mammaire : mission chirurgie en Nouvelle-Calédonie

Dans le cadre de son partenariat avec la Clinique Kuindo-Magnin à Nouméa, Gustave Roussy a mené une mission dédiée à la reconstruction mammaire immédiate et secondaire, dont des micro-chirurgies. Cette initiative constitue une première étape d’un transfert durable des compétences chirurgicales sur le territoire.

Un nouvel outil d’ia au service d’une détection optimale du cancer par imagerie

back to job offer list
back to clinical trials

Villejuif, le 7 avril 2026

Interception reçoit un financement de 6 millions d'euros : une étape décisive pour la prévention personnalisée des cancers à haut risque

back to job offer list
back to clinical trials

Villejuif, le 3 avril 2026

Pages